It should be noted that CGMS offer information on nocturnal glycemic values and could facilitate the timely initiation of insulin therapy for GDM, thereby avoiding pregnancy complications caused by exposure to hyperglycemia in utero [44,45,46]. This evidence concerns the gene INS and gestational diabetes.